The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study

The previous results of former clinical studies confirmed that first-line bevacizumab (BEV) in combination with chemotherapy improves clinical outcomes in patients with advanced non-squamous non-small cell lung cancer. The AVALANCHE study (ClinicalTrials.gov Identifier NCT03170284) was undertaken to...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolnay, Edina, Ghimessy, Áron Kristóf, Juhász, Erzsébet, Sztancsik, Zsuzsanna, Losonczy, György, Dombi, Péter, Vennes, Zsuzsanna, Helf, László, Csada, Edit, Sárosi, Veronika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341671/
https://www.ncbi.nlm.nih.gov/pubmed/30675234
http://dx.doi.org/10.3892/ol.2018.9766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341671/
https://www.ncbi.nlm.nih.gov/pubmed/30675234
http://dx.doi.org/10.3892/ol.2018.9766

Ejemplares similares